Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Bosotti

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Discovery of drug mode of action and drug repositioning from transcriptional responsesFrancesco Iorio, Roberta Bosotti, Emanuela Scacheri, et al.
Genomics, Proteomics & Bioinformatics|September 8, 2005
PoInTree: a polar and interactive phylogenetic treeMarco Carreras, Cerreras Marco, Eleonora Gianti, et al.
Genetic Testing and Molecular Biomarkers|January 30, 2013
Cell line identity finding by fingerprinting, an optimized resource for short tandem repeat profile authenticationAlessio Somaschini, Nadia Amboldi, Angelo Nuzzo, et al.
Cell Reports|September 13, 2025
Adducins regulate morphology and fate of neural progenitors during neocortical neurogenesisChiara Ossola, Nikola Cokorac, Emanuele Capra, et al.
Plos One|May 5, 2011
Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitroStefan Balabanov, Artur Gontarewicz, Gunhild Keller, et al.
Oncotarget|September 15, 2017
Identification and characterization of a novel <i>SCYL3-NTRK1</i> rearrangement in a colorectal cancer patientMassimo Milione, Elena Ardini, Jason Christiansen, et al.
BMC Genomics|April 25, 2019
Comprehensive kinome NGS targeted expression profiling by KING-REXGiovanni Carapezza, Carlo Cusi, Ettore Rizzo, et al.
Molecular Cancer Therapeutics|April 29, 2010
Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical studyGiuseppe Locatelli, Roberta Bosotti, Marina Ciomei, et al.
Molecular Cancer Therapeutics|December 15, 2017
Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and BrachyuryPaola Magnaghi, Barbara Salom, Liviana Cozzi, et al.
Scientific Reports|August 25, 2017
Establishment and genomic characterization of the new chordoma cell line Chor-IN-1Roberta Bosotti, Paola Magnaghi, Sebastiano Di Bella, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Discovery of drug mode of action and drug repositioning from transcriptional responsesFrancesco Iorio, Roberta Bosotti, Emanuela Scacheri, et al.
Genomics, Proteomics & Bioinformatics|September 8, 2005
PoInTree: a polar and interactive phylogenetic treeMarco Carreras, Cerreras Marco, Eleonora Gianti, et al.
Genetic Testing and Molecular Biomarkers|January 30, 2013
Cell line identity finding by fingerprinting, an optimized resource for short tandem repeat profile authenticationAlessio Somaschini, Nadia Amboldi, Angelo Nuzzo, et al.
Cell Reports|September 13, 2025
Adducins regulate morphology and fate of neural progenitors during neocortical neurogenesisChiara Ossola, Nikola Cokorac, Emanuele Capra, et al.
Plos One|May 5, 2011
Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitroStefan Balabanov, Artur Gontarewicz, Gunhild Keller, et al.
Oncotarget|September 15, 2017
Identification and characterization of a novel <i>SCYL3-NTRK1</i> rearrangement in a colorectal cancer patientMassimo Milione, Elena Ardini, Jason Christiansen, et al.
BMC Genomics|April 25, 2019
Comprehensive kinome NGS targeted expression profiling by KING-REXGiovanni Carapezza, Carlo Cusi, Ettore Rizzo, et al.
Molecular Cancer Therapeutics|April 29, 2010
Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical studyGiuseppe Locatelli, Roberta Bosotti, Marina Ciomei, et al.
Molecular Cancer Therapeutics|December 15, 2017
Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and BrachyuryPaola Magnaghi, Barbara Salom, Liviana Cozzi, et al.
Scientific Reports|August 25, 2017
Establishment and genomic characterization of the new chordoma cell line Chor-IN-1Roberta Bosotti, Paola Magnaghi, Sebastiano Di Bella, et al.
Pageof 3